Positive Outcomes for AML Patients Over 60

A study from the experts at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute shows new hope for patients over 60 who have acute myeloid leukemia (AML), a form of leukemia affecting the bone marrow cells. Stem cell transplantation is the most effective therapy for AML, and by designing a less toxic form of transplantation specifically for older patients – then further personalizing that treatment to each individual patient regardless of age – research specialists at The James found AML patients did remarkably well with their transplantation treatments. 

Steven Devine, MD, director of the blood and marrow transplant program, discusses this new hope in this week's Toward A Cancer Free World.